Bravera Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.6K Sell
28
-25
-47% -$25.5K 0.01% 203
2026
Q1
$48.7K Buy
53
+21
+66% +$21.3K 0.02% 192
2025
Q4
$34.4K Buy
+32
New +$30.6K 0.02% 195

Other funds holding LLY

Bravera Wealth's LLY Position: Q2 2026 in Review

Bravera Wealth reduced its Eli Lilly (LLY) stake by 47% in Q2 2026, selling an estimated $25.5K and leaving 28 shares worth $33.6K. The position accounts for 0.01% of the portfolio, ranked #203.

Bravera Wealth first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $48.7K in Q1 2026. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bravera Wealth held 28 shares of Eli Lilly worth $33.6K as of Q2 2026.
  • Bravera Wealth sold 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
  • Eli Lilly made up 0.01% of Bravera Wealth's portfolio in Q2 2026, its #203 holding.
  • Bravera Wealth first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Bravera Wealth's Eli Lilly position peaked at $48.7K in Q1 2026.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bravera Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.